Abbott Labs (ABT)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Abbott Labs | ABT | Healthcare | Medical Devices | 94 | 10.8% |
| Current Price (11/15) | $104.03 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 45,030.0 | |||
| Sales Growth Forecast | 6.0% | |||
| Net Profit Margin | 22.3% | |||
| Projected Shares Outstanding | 1,750.00 | |||
| EPS - Five year Forecast | $7.66 | |||
| Average P/E Ratio | 21.0 | |||
| Projected Average Price | $160.88 | |||
| Price Appreciation (Annualized) | 9.1% | |||
| Annual Dividend Yield | 1.7% | |||
| Projected Annual Return | 10.8% | |||
| Quality | ||||
| Financial Strength | 99 | 24.8 | ||
| EPS Stability | 94 | 23.5 | ||
| Industry Sales Growth Rate | 11.5% | 6.5 | ||
| Industry Net Profit Margin | 15.5% | 18.0 | ||
| Calculated Quality Rating | 74.6 | |||
| Fool CAPS | ||||
Total Players
2485
Outperforms
96
Underperforms
All-Stars (536)
526
Outperforms (98%)
10
Underperforms
|
||||
| Fundamental Data Updated: 11/11/2022 | ||||